Translating cancer genomes and transcriptomes for precision oncology
about
CRISPR/Cas9 therapeutics: a cure for cancer and other genetic diseasesIntegrating next-generation sequencing into clinical oncology: strategies, promises and pitfallsK-Ras mutation detection in liquid biopsy and tumor tissue as prognostic biomarker in patients with pancreatic cancer: a systematic review with meta-analysis.Big Data for Cancer Research.The combinatorial approach of laser-captured microdissection and reverse transcription quantitative polymerase chain reaction accurately determines HER2 status in breast cancer.From Clinical Standards to Translating Next-Generation Sequencing Research into Patient Care Improvement for Hepatobiliary and Pancreatic CancersExome Sequencing Identifies Potentially Druggable Mutations in Nasopharyngeal Carcinoma.Analysis of spatial heterogeneity in normal epithelium and preneoplastic alterations in mouse prostate tumor models.Molecular Subtyping of Pancreatic Cancer: Translating Genomics and Transcriptomics into the Clinic.Effect of method of deduplication on estimation of differential gene expression using RNA-seq.Transcriptome modeling and phenotypic assays for cancer precision medicine.Learning from the failures of drug discovery in B-cell non-Hodgkin lymphomas and perspectives for the future: chronic lymphocytic leukemia and diffuse large B-cell lymphoma as two ends of a spectrum in drug development.Androgen receptor and miR-206 regulation in prostate cancer.Beyond Seed and Soil: Understanding and Targeting Metastatic Prostate Cancer; Report From the 2016 Coffey-Holden Prostate Cancer Academy Meeting.Harnessing Solute Carrier Transporters for Precision Oncology.Rapid, ultra low coverage copy number profiling of cell-free DNA as a precision oncology screening strategy.The Transcriptomic Signature Of Disease Development And Progression Of Nonalcoholic Fatty Liver Disease.Personalized medicine-a modern approach for the diagnosis and management of hypertension.New challenges to psycho-oncology research: Precision medicine oncology and targeted therapies.Challenging Standard-of-Care Paradigms in the Precision Oncology Era.PRECISION ONCOLOGY DECISION SUPPORT: CURRENT APPROACHES AND STRATEGIES FOR THE FUTURE.From somatic variants towards precision oncology: Evidence-driven reporting of treatment options in molecular tumor boards.Role of COL6A3 in colorectal cancer.Sprouty2 loss-induced IL6 drives castration-resistant prostate cancer through scavenger receptor B1.Live-single-cell phenotypic cancer biomarkers-future role in precision oncology?Applications of RNA Indexes for Precision Oncology in Breast CancerBiomarkers: paving stones on the road towards the personalized precision medicine for oral squamous cell carcinomaSwissMTB: establishing comprehensive molecular cancer diagnostics in Swiss clinicsPancreatic cancer subtypes: a roadmap for precision medicineThe Mouse Hospital and Its Integration in Ultra-Precision Approaches to Cancer Care
P2860
Q26744172-28E970B9-4D4A-4384-9C22-23984FB1C0DDQ28066709-013DDDCD-50B1-4FC5-B157-6366C265EC71Q30250097-9ACDA336-8784-4846-BD64-580894E9219AQ31035723-13F184F2-CADF-4042-BA70-25FE5D6876CCQ35983341-FEAC5908-C7AA-46D9-9B71-D11A5A334D59Q37631655-61DAA3EB-ABCF-4C01-AE84-1707E534EB87Q37678950-4CCB8A6C-2D80-4011-BFB6-A0EFC4E2E9EEQ37710893-12DF1AFA-180F-4F77-B033-3C878DEF8E49Q37726365-83DFE1AE-F15C-4F05-9594-995A7969F1F7Q38379253-9BB0B7C9-0E84-4134-91D3-209E30815BD3Q38400577-33FEFAC6-3E87-4BAB-BAC0-B187AFB9A432Q38685006-A183085A-D33F-4C97-A5F6-0D1A11CBC12BQ38946793-6A74B2ED-60DA-41D4-9223-6F7E4684229FQ38966736-7C9236C8-D627-4F83-BA5D-1924F4BEF388Q39204754-FF7181F6-570A-4932-A040-E2F412745DDAQ46007270-3FCE6B03-E21D-4215-94DC-A712FA485293Q46606052-88ADAF78-5B66-4FD1-88C3-D5D9B16AD506Q47095825-2D46A7D5-86B0-4332-B9DD-F1A2EED5A67EQ47987953-DCDC3FDB-30C2-47C5-A456-5FA11A1DA5DFQ49835188-3B65B4C6-3875-4C48-B535-13943662F5B9Q50115884-B08E7F4B-28C4-4105-8998-6CBADC61F84AQ52354170-DF1D4230-433B-4BD2-A513-79D6DA3FF64FQ52721418-233C24C1-D0EC-47A2-ABB0-44E5F65E12A4Q54982147-AECAA766-7B99-4149-90DD-A5E091943118Q55397731-CA825162-0D55-45F1-9184-BE85425D5EF6Q57113927-A09827A4-8ADC-461E-A2E2-8165D7E7311DQ57152715-62BEC654-B86D-4305-A1E9-C4777E26FA05Q58101254-0DA6E51E-37D4-4AE1-BA0B-6EBD22C29ADCQ58146806-B2CEFC6C-28D5-4911-AE09-F7F3D66356FCQ58697933-D083D562-6058-460E-9D4E-4984D73C7A29
P2860
Translating cancer genomes and transcriptomes for precision oncology
description
2016 nî lūn-bûn
@nan
2016 թուականին հրատարակուած գիտական յօդուած
@hyw
2016 թվականին հրատարակված գիտական հոդված
@hy
2016年の論文
@ja
2016年論文
@yue
2016年論文
@zh-hant
2016年論文
@zh-hk
2016年論文
@zh-mo
2016年論文
@zh-tw
2016年论文
@wuu
name
Translating cancer genomes and transcriptomes for precision oncology
@ast
Translating cancer genomes and transcriptomes for precision oncology
@en
Translating cancer genomes and transcriptomes for precision oncology
@nl
type
label
Translating cancer genomes and transcriptomes for precision oncology
@ast
Translating cancer genomes and transcriptomes for precision oncology
@en
Translating cancer genomes and transcriptomes for precision oncology
@nl
prefLabel
Translating cancer genomes and transcriptomes for precision oncology
@ast
Translating cancer genomes and transcriptomes for precision oncology
@en
Translating cancer genomes and transcriptomes for precision oncology
@nl
P2860
P3181
P356
P1433
P1476
Translating cancer genomes and transcriptomes for precision oncology
@en
P2093
Arul M Chinnaiyan
Sameek Roychowdhury
P2860
P3181
P356
10.3322/CAAC.21329
P407
P577
2016-01-01T00:00:00Z